Jane Wasman, Executive VP, General Counsel & Secretary at ACORDA THERAPEUTICS INC (ACOR), sold 7,344 shares at $22.92 ($168K) on 2011-12-01, disclosed to the SEC on 2011-12-05.
Scheduled sale ($168k) by Executive VP, General Counsel & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-12-06 | $126K | — | Filing → |
| ACOR | SELL | 2018-01-23 | $1.9M | — | Filing → |
| ACOR | SELL | 2017-12-05 | $187K | — | Filing → |